Boston Financial Mangement LLC Novo Nordisk A S Transaction History

Boston Financial Mangement LLC

$3.23 Billion
Q3 2024

A detailed history of Boston Financial Mangement LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Boston Financial Mangement LLC holds 17,307 shares of NVO stock, worth $1.76 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

17,307

Previous 43,482 60.2%

Holding current value

$1.76 Million

Previous $6.21 Million 66.81%

% of portfolio

0.06%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$119.07 - $145.42 $3.12 Million - $3.81 Million	-26,175 Reduced 60.2%	17,307 $2.06 Million
Q2 2024 Jul 29, 2024	BUY	$122.71 - $146.91 $4,540 - $5,435	37 Added 0.09%	43,482 $6.21 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $68,924 - $91,745	675 Added 1.58%	43,445 $5.58 Million
Q4 2023 Feb 12, 2024	SELL	$87.78 - $105.45 $39,501 - $47,452	-450 Reduced 1.04%	42,770 $4.42 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $1.99 Million - $4.37 Million	21,896 Added 102.68%	43,220 $3.93 Million
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $205,269 - $227,207	-1,316 Reduced 5.81%	21,324 $3.45 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $350,568 - $421,561	-2,649 Reduced 10.47%	22,640 $3.6 Million
Q4 2022 Jan 27, 2023	SELL	$102.55 - $135.33 $22,971 - $30,313	-224 Reduced 0.88%	25,289 $0
Q3 2022 Nov 09, 2022	BUY	$95.28 - $116.93 $114,336 - $140,316	1,200 Added 4.94%	25,513 $2.54 Million
Q2 2022 Aug 08, 2022	SELL	$103.24 - $121.81 $1,135 - $1,339	-11 Reduced 0.05%	24,313 $2.71 Million
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $63,307 - $76,527	-680 Reduced 2.72%	24,324 $2.7 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $41,516 - $50,695	-433 Reduced 1.7%	25,004 $2.8 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $51,665 - $65,251	-612 Reduced 2.35%	25,437 $2.44 Million
Q2 2021 Aug 03, 2021	SELL	$67.66 - $84.76 $5,751 - $7,204	-85 Reduced 0.33%	26,049 $2.18 Million
Q1 2021 May 07, 2021	SELL	$67.06 - $75.82 $176,032 - $199,027	-2,625 Reduced 9.13%	26,134 $1.76 Million
Q4 2020 Feb 10, 2021	SELL	$63.89 - $73.8 $104,587 - $120,810	-1,637 Reduced 5.39%	28,759 $2.01 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $24,839 - $27,385	-390 Reduced 1.27%	30,396 $2.11 Million
Q2 2020 Aug 10, 2020	SELL	$58.54 - $67.94 $14,635 - $16,985	-250 Reduced 0.81%	30,786 $2.02 Million
Q1 2020 May 05, 2020	SELL	$49.46 - $64.78 $495,836 - $649,419	-10,025 Reduced 24.41%	31,036 $1.87 Million
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $114,179 - $133,415	-2,290 Reduced 5.28%	41,061 $2.38 Million
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $23,770 - $26,715	-500 Reduced 1.14%	43,351 $2.24 Million
Q2 2019 Jul 24, 2019	SELL	$46.79 - $52.47 $8.39 Million - $9.41 Million	-179,286 Reduced 80.35%	43,851 $2.24 Million
Q1 2019 Apr 25, 2019	SELL	$46.36 - $52.63 $55,678 - $63,208	-1,201 Reduced 0.54%	223,137 $11.7 Million
Q4 2018 Jan 31, 2019	BUY	$41.54 - $47.25 $526,934 - $599,366	12,685 Added 5.99%	224,338 $10.3 Million
Q3 2018 Nov 02, 2018	SELL	$46.76 - $51.24 $14,121 - $15,474	-302 Reduced 0.14%	211,653 $9.98 Million
Q2 2018 Aug 03, 2018	SELL	$44.29 - $50.42 $116,925 - $133,108	-2,640 Reduced 1.23%	211,955 $9.78 Million
Q1 2018 Apr 25, 2018	SELL	$48.49 - $58.14 $237,843 - $285,176	-4,905 Reduced 2.23%	214,595 $10.6 Million
Q4 2017 Feb 05, 2018	BUY	$47.53 - $53.73 $8,412 - $9,510	177 Added 0.08%	219,500 $11.8 Million
Q3 2017 Oct 30, 2017	BUY	$41.15 - $49.22 $9.03 Million - $10.8 Million	219,323	219,323 $10.6 Million

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Account

Boston Financial Mangement LLC Novo Nordisk A S Transaction History